JPH0411215B2 - - Google Patents
Info
- Publication number
- JPH0411215B2 JPH0411215B2 JP59200131A JP20013184A JPH0411215B2 JP H0411215 B2 JPH0411215 B2 JP H0411215B2 JP 59200131 A JP59200131 A JP 59200131A JP 20013184 A JP20013184 A JP 20013184A JP H0411215 B2 JPH0411215 B2 JP H0411215B2
- Authority
- JP
- Japan
- Prior art keywords
- bone
- hydroxyapatite
- artificial
- particle size
- physiological saline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Porous Artificial Stone Or Porous Ceramic Products (AREA)
Description
【発明の詳細な説明】
産業上の利用分野
本発明は歯科、口腔外科、整形外科などの治療
用として好適な人工骨材料に関し、さらに詳しく
は、生体の骨腫瘍その他によつて生じる骨欠損部
や空隙部に充てんして当該個所の新生骨の形成を
促進し、それ自体が生体の骨組織と一体化しうる
生体親和性に優れた顆粒状の多孔質水酸アパタイ
ト焼結体と生理食塩水とから成る人工骨材料用組
成物に関するものである。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to an artificial bone material suitable for treatment in dentistry, oral surgery, orthopedic surgery, etc., and more particularly, it relates to artificial bone materials suitable for treatment in dentistry, oral surgery, orthopedic surgery, etc. A granular porous hydroxyapatite sintered body with excellent biocompatibility that can be filled into voids and promote the formation of new bone in the area and integrate with the bone tissue of the living body, and physiological saline. The present invention relates to an artificial bone material composition comprising:
従来の技術
従来、歯科治療においては、抜歯後歯槽骨が吸
収されて、入れ歯などの固定が不十分になるとい
う問題があり、また口腔外科や整形外科治療にお
いては、例えば交通事故や骨腫瘍などの疾患によ
り、失なわれた骨を補綴するために、患者自身の
他の部分の骨すなわち自家骨の移植などが試みら
れているが、損傷個所以外の骨組織を切除するこ
とから、患者の肉体的及び心理的負担が極めて大
きいという問題や、広範な骨欠損部を充てんする
には十分な量の自家骨を採取できないという問題
などがあつた。Conventional technology Conventionally, in dental treatment, there has been a problem in which the alveolar bone is resorbed after tooth extraction, making it impossible to secure dentures etc. In addition, in oral surgery and orthopedic treatment, there has been a problem in cases such as traffic accidents, bone tumors, etc. In order to replace the bone lost due to this disease, attempts have been made to transplant bone from other parts of the patient, that is, autologous bone, but since bone tissue other than the damaged area is removed, the patient's There were problems such as the extremely heavy physical and psychological burden and the inability to collect enough autologous bone to fill in extensive bone defects.
このような事情の下で、近年人工歯根や人工骨
材に関する研究が盛んに行われるようになつてき
ている。これらの人工骨の材料については、生体
内に埋入入するに際して、毒性がなく安全で、か
なりの機械的強度を有し、かつ生体組織と結合し
やすいものを選ぶことが必要とされ、さらに生体
内で自然に消失して新生骨と置換されるものが好
ましいとされている。 Under these circumstances, research on artificial tooth roots and artificial aggregates has been actively conducted in recent years. When implanting these artificial bones into a living body, it is necessary to select materials that are non-toxic, safe, have considerable mechanical strength, and are easy to bond with living tissue. It is said that it is preferable to use a material that naturally disappears in vivo and is replaced by new bone.
このような要件を満たす材料として、近年リン
酸カルシウム、水酸アパタイト又は特殊なアパタ
イト型結晶構造リン酸カルシウム化合物の焼結体
が注目されており、これらを用いた人工骨、人工
関節、人工歯根などの研究が盛んに行われてい
る。 In recent years, sintered bodies of calcium phosphate, hydroxyapatite, or calcium phosphate compounds with a special apatite-type crystal structure have been attracting attention as materials that meet these requirements, and research using these materials into artificial bones, artificial joints, artificial tooth roots, etc. is progressing. It is being actively carried out.
ところで、人工骨や人工歯根を体内に埋入した
ときに、生体組織と結合しやすくするには、これ
を多孔質のものとして生体組織が細孔に入り込
み、これを固定しうるようにすることが必要であ
り、この目的を達成するために、例えば孔径0.03
〜1.2mm程度の気孔を有する多孔質リン酸カルシ
ウム系焼結体を用いることが提案されている(特
開昭56−149389号公報、特開昭57−7856号公報)。 By the way, when an artificial bone or tooth root is implanted into the body, in order to make it easier to bond with living tissue, it is necessary to make it porous so that the living tissue can enter the pores and fix it. and to achieve this purpose, e.g. pore size 0.03
It has been proposed to use a porous calcium phosphate sintered body having pores of about 1.2 mm (Japanese Patent Application Laid-Open Nos. 149389-1989 and 7856-1985).
しかしながら、この多孔質リン酸カルシウム系
焼結体から成る人工骨材は、硬くてもろいなど、
機械的強度が十分でないという欠点があり、また
素材がち密質であるため、生体内における吸収や
新生骨の置換などに関して必ずしも満足しうるも
のではない。 However, this artificial aggregate made of porous calcium phosphate sintered material is hard and brittle.
It has the drawback of not having sufficient mechanical strength, and since the material is dense, it is not necessarily satisfactory in terms of in-vivo absorption and replacement of new bone.
さらに、結晶粒径が50Å〜10μmのアパタイト
型結晶構造リン酸カルシウム化合物の粉粒体に生
理食塩水などを加えて流動状態又は可塑状態とし
た骨欠損部充てん材が提案されている(特開昭56
−54841号公報)。しかしながら、この充てん材に
おいては、使用するリン酸カルシウム化合物が微
粉状であるため、このものを骨欠損部に充てんし
て、縫合る際に、該微粉状物が皮膚創傷面に付着
して縫合が困難であるという欠点がある。 Furthermore, a bone defect filling material has been proposed in which a powder of an apatite-type crystal structure calcium phosphate compound with a crystal grain size of 50 Å to 10 μm is made into a fluid or plastic state by adding physiological saline etc.
−54841). However, since the calcium phosphate compound used in this filling material is in the form of fine powder, when this material is filled into the bone defect and sutured, the fine powder adheres to the surface of the skin wound, making suturing difficult. It has the disadvantage of being.
発明が解決しようとする問題点
本発明の目的は、このような欠点を改良し、骨
欠損部や空隙部に充てんして、当該個所の新生骨
の形成を促進し、それ自体が骨組織と一体化しう
る生体親和性に優れたものであり、その上手術の
際に何ら弊害を伴わないような人工骨材料用組成
物を提供することにある。Problems to be Solved by the Invention The purpose of the present invention is to improve the above-mentioned drawbacks, fill bone defects and voids, promote the formation of new bone in the area, and make the bone itself form bone tissue. The object of the present invention is to provide a composition for an artificial bone material that can be integrated into one body, has excellent biocompatibility, and does not cause any adverse effects during surgery.
問題を解決するための手段
本発明者らは、先に人工骨材として好適な孔径
10〜100μmの連続気孔を有する水酸アパタイト
焼結体を開発したが(特願昭58−129087号)、さ
らに研究を重ねた結果、前記焼結体を用いて気孔
率20〜30%、粒径0.1〜2.0mmの顆粒状に造粒し、
このものに生理食塩水を加えて成る人工骨材料が
前記目的に適合しうることを見出し、この知見に
基づいて本発明を完成するに至つた。Means for Solving the Problem The present inventors have previously determined the pore size suitable for artificial aggregate.
A hydroxyapatite sintered body with continuous pores of 10 to 100 μm was developed (Japanese Patent Application No. 129087/1987), but as a result of further research, it was found that the sintered body had a porosity of 20 to 30% and a grain size of 20 to 30%. Granulate into granules with a diameter of 0.1 to 2.0 mm,
We have found that an artificial bone material made by adding physiological saline to this material can meet the above purpose, and based on this knowledge, we have completed the present invention.
孔径10〜100μmの連続気孔を有し、かつ気孔
率が20〜30%、粒径0.1〜2.0mmの顆粒状の多孔質
水酸アパタイト焼結体と生理食塩水とから成り、
かつ該焼結体と生理食塩水との割合が重量比で
2:1ないし1:2の範囲にある人工骨材料用組
成物を提供するものである。 It consists of a granular porous hydroxyapatite sintered body having continuous pores with a pore size of 10 to 100 μm, a porosity of 20 to 30%, and a particle size of 0.1 to 2.0 mm, and physiological saline,
The present invention also provides a composition for an artificial bone material in which the weight ratio of the sintered body to physiological saline is in the range of 2:1 to 1:2.
本発明の人工骨材料に用いる顆粒状の多孔質水
酸アパタイト焼結体は、例えば平均粒径0.1〜10μ
mの水酸アパタイト粉末100重量部に対し、平均
粒径10〜100μmの熱分解性物質約25〜100重量部
を加え、公知の方法により粒径0.1〜3.0mmの顆粒
に造粒した後900〜1400℃の温度で焼成すること
によつて製造することができる。なお、焼成は加
圧せずに行うこともできるが、例えばホツトプレ
スを用いて300〜1000Kg/cm2の圧力を加えて行う
のが好ましい。 The granular porous hydroxyapatite sintered body used for the artificial bone material of the present invention has an average particle size of 0.1 to 10μ, for example.
Approximately 25 to 100 parts by weight of a thermally decomposable substance with an average particle size of 10 to 100 μm is added to 100 parts by weight of hydroxyapatite powder of 900 μm, and the mixture is granulated into granules with a particle size of 0.1 to 3.0 mm by a known method. It can be produced by firing at a temperature of ~1400°C. Although the firing can be carried out without applying pressure, it is preferable to carry out the firing by applying a pressure of 300 to 1000 kg/cm 2 using a hot press, for example.
この際用いる水酸アパタイトは、乾式法又は湿
式法による合成アパタイトでもよいし、各種脊椎
動物の骨、歯から回収された生体アパタイトでも
よい。この原料の水酸アパタイトはできるだけ微
粉状に粉砕したものを用いるのが望ましいが、粉
砕機、分級機などの装置的制限や取扱い上の問題
もあるため、通常は、平均粒径0.1〜10μmの範囲
のものが用いられる。 The hydroxyapatite used at this time may be apatite synthesized by a dry method or a wet method, or may be a living body apatite recovered from the bones and teeth of various vertebrates. It is desirable to use this raw material, hydroxyapatite, that has been ground into as fine a powder as possible, but due to limitations in equipment such as grinders and classifiers, and handling problems, it is usually used with an average particle size of 0.1 to 10 μm. A range is used.
次に、熱分解性物質は、水酸アパタイトを焼結
する際に所望の孔径をもつ連続気孔を形成させる
ために配合させるものであるから、平均粒径10〜
100μmを有するものでなければならない。この
熱分解性物質は、気孔率20〜30%のものを得るた
めに、水酸アパタイト粉末100重量部当り約25〜
100重量部の割合で加えることが望ましい。気孔
率が20%未満では十分な連続気孔が形成されない
し、また、人工骨としては、圧縮強度が少なくと
も50Kg/cm2の材料を用いるのが好ましいが、この
程度の強度を確保するには気孔率を30%以下にす
ることが必要である。この熱分解性物質として
は、結晶性セルロースのような有機化合物が好適
である。 Next, the thermally decomposable substance is blended in order to form continuous pores with a desired pore size when sintering hydroxyapatite, so the average particle size is 10 to 10.
Must have a diameter of 100 μm. This pyrolyzable material is used per 100 parts by weight of hydroxyapatite powder to obtain a porosity of 20 to 30%.
It is desirable to add it in a proportion of 100 parts by weight. If the porosity is less than 20%, sufficient continuous pores will not be formed, and although it is preferable to use a material with a compressive strength of at least 50 kg/cm 2 as an artificial bone, in order to ensure this level of strength, the pores cannot be formed. It is necessary to keep the ratio below 30%. As this thermally decomposable substance, an organic compound such as crystalline cellulose is suitable.
水酸アパタイト粉末と結晶性セルロースとの混
合は、両者が均一に混合しうるような手段であれ
ばどのような手段を用いてもよい。例えば水酸ア
パタイト粉末と結晶性セルロースをそのまま適当
な混合機を用いて混合してもよいし、また水酸ア
パタイト粉末を、あらかじめ粒径20〜200μm顆
粒状に成形し、これと結晶性セルロースとを混合
してもよい。さらに、結晶性セルロースの表面を
水その他の溶媒で湿潤させ、これに水酸アパタイ
トを均一に付着させる方法をとることもできる。 Any means may be used to mix the hydroxyapatite powder and crystalline cellulose as long as they can be mixed uniformly. For example, hydroxyapatite powder and crystalline cellulose may be mixed as is using an appropriate mixer, or hydroxyapatite powder may be formed into granules with a particle size of 20 to 200 μm and then mixed with crystalline cellulose. may be mixed. Furthermore, it is also possible to wet the surface of crystalline cellulose with water or other solvent and apply hydroxyapatite uniformly thereto.
このようにして調製した混合物に、必要に応じ
てポリビニルアルコールのようなバインダーを加
え、所望の形状に成形し900〜1400℃の温度にお
いて焼成する。焼成時間は、通常0.5〜3時間で
ある。 A binder such as polyvinyl alcohol is added to the mixture thus prepared, if necessary, and the mixture is molded into a desired shape and fired at a temperature of 900 to 1400°C. Firing time is usually 0.5 to 3 hours.
本発明においては、顆粒の粒径は0.1〜2.0mmの
範囲である。この粒径が0.1mm未満では、骨欠損
部などに充てんして縫合する際に、このものが皮
膚創傷面に付着して縫合が困難になり、また2mm
を超えると、このものに生理食塩水を加えた場
合、均一なスラリーが形成されず、手術の際の取
り扱いが困難となる。 In the present invention, the particle size of the granules ranges from 0.1 to 2.0 mm. If the particle size is less than 0.1 mm, when filling and suturing bone defects etc., this particle will adhere to the surface of the skin wound and suturing will be difficult;
If the slurry exceeds this amount, a uniform slurry will not be formed when physiological saline is added to the slurry, making it difficult to handle during surgery.
本発明の人工骨材料用組成物は、このようにし
て得られた顆粒状の多孔質水酸アパタイト焼結体
に生理食塩水を加えて成る均一なスラリー状のも
のである。前記の水酸アパタイト焼結体と生理食
塩水との割合は、重量比で2:1ないし1:2の
範囲とする必要がある。水酸アパタイト焼結体の
割合がこれよりも多すぎると流動性を欠いて円滑
な充てんができないし、また生理食塩水の割合が
これよりも多すぎると焼結体の濃度が不足して流
出しやすくなり充てんが不完全になるのを免れな
い。 The composition for artificial bone material of the present invention is in the form of a uniform slurry, which is obtained by adding physiological saline to the thus obtained granular porous hydroxyapatite sintered bodies. The ratio of the hydroxyapatite sintered body to the physiological saline needs to be in the range of 2:1 to 1:2 by weight. If the proportion of sintered hydroxyapatite is too high, it will lack fluidity and cannot be filled smoothly, and if the proportion of physiological saline is too high, the concentration of the sintered body will be insufficient and it will flow out. This will inevitably lead to incomplete filling.
発明の効果
本発明の人工骨材料は、孔径10〜100μmの連
続気孔を有し、かつ気孔率が20〜30%である粒径
0.1〜2.0mmの顆粒状多孔質アバタイト焼結体を用
いているため、骨欠損部や空隙部に充てんした場
合、生体組織と結合しやすく、また生体内におい
て破骨細胞(50〜100μm)が気孔内に入り、そ
の作用を受けて迅速に溶解吸収され、骨芽細胞に
より新生骨と完全に置換されるという特徴があ
り、また縫合の際に、皮膚創傷面に付着すること
がないので、手術を容易に行うことができる。し
たがつて、本発明の人工骨材料は歯科、口腔外
科、整形外科などの治療に好適である。Effects of the invention The artificial bone material of the present invention has a particle size that has continuous pores with a pore size of 10 to 100 μm and a porosity of 20 to 30%.
Because it uses granular porous abatite sintered bodies with a size of 0.1 to 2.0 mm, when it is filled into bone defects or voids, it easily bonds with living tissue, and osteoclasts (50 to 100 μm) do not form in vivo. It has the characteristic that it enters the pores, is rapidly dissolved and absorbed by the action, and is completely replaced by new bone by osteoblasts, and does not adhere to the skin wound surface during suturing. Surgery can be performed easily. Therefore, the artificial bone material of the present invention is suitable for treatments such as dentistry, oral surgery, and orthopedics.
実施例
次に実施例によつて本発明をさらに詳細に説明
する。EXAMPLES Next, the present invention will be explained in more detail with reference to Examples.
例
湿式法で合成した水酸アパタイトを900℃にお
いて1時間仮焼したのち、ボールミルを用いて平
均粒径0.5μmに粉砕した。次いでこのもの100重
量部にポリビニルアルコール2重量部及び平均粒
径50μmの結晶セルロース粉末50重量部を加え、
混合したのち、これを粒径0.5〜3.0mmの顆粒に造
粒し、昇温速度100℃/時で1350℃まで加熱し
1350℃において1時間焼結して、平均孔径50μm
の連続気孔を有する、気孔率26%の水酸アパタイ
トの顆粒状焼結体を得た。Example Hydroxyapatite synthesized by a wet method was calcined at 900°C for 1 hour, and then ground to an average particle size of 0.5 μm using a ball mill. Next, 2 parts by weight of polyvinyl alcohol and 50 parts by weight of crystalline cellulose powder with an average particle size of 50 μm were added to 100 parts by weight of this material.
After mixing, this was granulated into granules with a particle size of 0.5 to 3.0 mm, and heated to 1350°C at a heating rate of 100°C/hour.
Sintered at 1350℃ for 1 hour, average pore size 50μm
A granular sintered body of hydroxyapatite with a porosity of 26% and continuous pores was obtained.
このようにして得られた顆粒状の多孔質水酸ア
パタイト焼結体100重量部に生理食塩水100重量部
を加えスラリー状となして、本発明の人工骨材料
を得た。 100 parts by weight of physiological saline was added to 100 parts by weight of the granular porous hydroxyapatite sintered body thus obtained to form a slurry, thereby obtaining the artificial bone material of the present invention.
比較例
実施例と同様にして、粒径5〜10μmの粉末状
の多孔質水酸アパタイト焼結物(実施例における
顆粒に造粒する前のもの)を作成し、このもの
100重量部に生理食塩水100重量部を加えスラリー
状となして、人工骨材料を得た。Comparative Example A porous hydroxyapatite sintered powder with a particle size of 5 to 10 μm (before granulation in the example) was prepared in the same manner as in the example.
An artificial bone material was obtained by adding 100 parts by weight of physiological saline to 100 parts by weight to form a slurry.
適用例
例で得た人工骨材料を、ウサギの下顎骨内の骨
欠損部に充てんする手術を行つたところ、皮膚創
傷面への付着は全く認められず、縫合は極めて容
易であつた。Application Example When a surgery was performed to fill the bone defect in the mandible of a rabbit with the artificial bone material obtained in Example, no adhesion to the skin wound surface was observed and suturing was extremely easy.
この手術後の骨組織について12週後及び24週後
に顕微鏡で観察したところ、以下の知見を得た。 When the bone tissue after this surgery was observed under a microscope 12 and 24 weeks later, the following findings were obtained.
12週後において、水酸アパタイト顆粒の間隙に
形成された新生骨組織は、厚さと密度を増すとと
もに層板構造もはつきり認められる。また、一部
には破骨細胞が出現し、水酸アパタイト顆粒に接
して形成された層板構造の新生骨を新生骨を吸収
している状態も認められ、活発な骨改造機転の進
行がうかがわれる。さらに、嵌植された水酸アパ
タイト顆粒の占める割合も減少している。 After 12 weeks, the new bone tissue formed between the hydroxyapatite granules increases in thickness and density, and a lamellar structure is clearly observed. In addition, osteoclasts appeared in some areas and were found to be resorbing new bone with a lamellar structure formed in contact with hydroxyapatite granules, indicating the progress of active bone remodeling mechanisms. be seen. Furthermore, the proportion occupied by the implanted hydroxyapatite granules is also reduced.
他方、母床骨骨膜にほぼ正常となり、母床骨外
側面の新生骨は層板構造を示し、その縁辺に1層
の骨芽細胞の配列が認められる。 On the other hand, the periosteum of the parent bone is almost normal, and the new bone on the lateral surface of the parent bone shows a lamellar structure, with a single layer of osteoblasts arranged on its edge.
24週後において、水酸アパタイト顆粒の間隙に
形成された新生骨はいつそう厚く、ち密になり、
新生骨の間に水酸アパタイト顆粒が散在する状態
になつている。また、新生骨の骨小腔の配例が規
則的になり、層板は顎骨の長軸方向に配列してい
るのが分る。さらに、拡大したハバース管や骨髄
の形成が認められ、水酸アパタイト顆粒は消失
し、そのあとに網目状の骨組織や不規則な骨組織
の形成が認められる。 After 24 weeks, the new bone formed between the hydroxyapatite granules becomes thicker and denser.
Hydroxyapatite granules are scattered between the new bones. It can also be seen that the arrangement of the lacunae in the new bone is regular, and the lamellae are arranged in the longitudinal direction of the jawbone. Furthermore, the formation of enlarged Haversian canals and bone marrow is observed, and the hydroxyapatite granules disappear, followed by the formation of mesh-like bone tissue and irregular bone tissue.
比較適用例
比較例で得た人工骨材料を、適用例と同様にし
てウサギの下顎骨内の骨欠損部に充てんする手術
を行つたところ、材料が皮膚創傷面に付着して縫
合が困難であつた。Comparative Application Example When the artificial bone material obtained in the comparative example was used to fill a bone defect in the mandible of a rabbit in the same manner as in the application example, the material adhered to the skin wound surface and suturing was difficult. It was hot.
また、12週後及び24週後の骨組織の変化を顕微
鏡により観察したところ以下の知見を得た。 In addition, changes in bone tissue after 12 and 24 weeks were observed using a microscope, and the following findings were obtained.
12週後において、母床骨骨膜の状態は、適用例
の場合と同様であり、外側に厚い層板骨が認めら
れる。すなわち、顆粒間隙の新生組織は、厚さと
密度を増し、ち密化している。新生骨組織には、
直接水酸アパタイト顆粒と結合しているものが多
くみられるのが顆粒の外形変化は認められない。 After 12 weeks, the condition of the parent bone periosteum was the same as in the applied example, and thick lamellar bone was observed on the outside. That is, the new tissue in the intergranular spaces increases in thickness and density, and becomes compact. New bone tissue includes
Many of them are directly bonded to hydroxyapatite granules, but no change in the external shape of the granules is observed.
24週後において、顆粒間隙は、新生骨組織により
満たされているが、線維性結合組織が水酸アパタ
イト顆粒を取り囲んでいる状態も認められる。After 24 weeks, the intergranular spaces were filled with new bone tissue, but fibrous connective tissue was also observed surrounding the hydroxyapatite granules.
適用例と比較して、線維結合組織が多いが、直
接水酸アパタイト顆粒と結合している部位では骨
組織の活性が低く、改造機転の進行はゆるやかで
ある。 Compared to the applied example, there is more fibrous connective tissue, but the activity of bone tissue is low in areas directly connected to hydroxyapatite granules, and the remodeling mechanism progresses slowly.
Claims (1)
孔率が20〜30%、粒径0.1〜2.0mmの顆粒状の多孔
質水酸アパタイト焼結体と生理食塩水とから成
り、かつ該焼結体と生理食塩水との割合が重量比
で2:1ないし1:2の範囲にある人工骨材料用
組成物。1 Consisting of a granular porous hydroxyapatite sintered body having continuous pores with a pore size of 10 to 100 μm, a porosity of 20 to 30%, and a particle size of 0.1 to 2.0 mm, and physiological saline, and A composition for artificial bone material in which the weight ratio of solids to physiological saline is in the range of 2:1 to 1:2.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59200131A JPS6179464A (en) | 1984-09-25 | 1984-09-25 | Composition for artificial bone material |
| US06/770,722 US4629464A (en) | 1984-09-25 | 1985-08-29 | Porous hydroxyapatite material for artificial bone substitute |
| DE19853531144 DE3531144A1 (en) | 1984-09-25 | 1985-08-30 | POROESES HYDROXYAPATITE MATERIAL AND ITS USE |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59200131A JPS6179464A (en) | 1984-09-25 | 1984-09-25 | Composition for artificial bone material |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62266204A Division JPS63294864A (en) | 1987-10-23 | 1987-10-23 | Preparation of artificial bone material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6179464A JPS6179464A (en) | 1986-04-23 |
| JPH0411215B2 true JPH0411215B2 (en) | 1992-02-27 |
Family
ID=16419317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59200131A Granted JPS6179464A (en) | 1984-09-25 | 1984-09-25 | Composition for artificial bone material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6179464A (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62281953A (en) * | 1986-05-28 | 1987-12-07 | 旭光学工業株式会社 | Bone filler and its production |
| JPH062153B2 (en) * | 1987-09-18 | 1994-01-12 | 三菱マテリアル株式会社 | Filling material for bone defect and bone void |
| JPH021285A (en) * | 1988-01-11 | 1990-01-05 | Asahi Optical Co Ltd | Fixable dental and medical granular bone filler, fixing method thereof and bone prosthetic material |
| GB2227176B (en) * | 1988-12-12 | 1993-01-20 | Bioplasty Inc | Textured micro implants |
| JP2657847B2 (en) * | 1990-05-10 | 1997-09-30 | 寅雄 大塚 | Hydroxyapatite porous biofill material and method for producing the same |
| JPH0440961A (en) * | 1990-06-06 | 1992-02-12 | Mitsubishi Materials Corp | Filler for bone omission part, bone cavity part, and bone absorption part |
| JPH0930988A (en) * | 1995-07-21 | 1997-02-04 | Sumitomo Osaka Cement Co Ltd | Sustained release porous ceramic molding for medicine and its production |
| WO2005102405A1 (en) * | 2004-04-23 | 2005-11-03 | Kotze Jacobus Adriaan Albertus | Ceramic bulking agent |
| JP2008173238A (en) * | 2007-01-17 | 2008-07-31 | Olympus Terumo Biomaterials Corp | Manufacturing method of biological tissue filling material |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142857A (en) * | 1983-12-29 | 1985-07-29 | 住友セメント株式会社 | Bone cement composition |
-
1984
- 1984-09-25 JP JP59200131A patent/JPS6179464A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6179464A (en) | 1986-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Costantino et al. | Hydroxyapatite cement: I. Basic chemistry and histologic properties | |
| US6287341B1 (en) | Orthopedic and dental ceramic implants | |
| EP2252338B1 (en) | Bone graft material and uses thereof | |
| CA2270185C (en) | Method of preparing a poorly crystalline calcium phosphate and methods of its use | |
| US8303976B2 (en) | Inorganic shaped bodies and methods for their production and use | |
| JP3658172B2 (en) | A storage stable formulation for calcium phosphate minerals prepared in situ | |
| JP2003506193A (en) | Composite molded body and method for producing and using the same | |
| JPS6222632B2 (en) | ||
| JPS6343106B2 (en) | ||
| EP0984902A1 (en) | Method for preparing a biomaterial based on hydroxyapatite, resulting biomaterial and surgical or dental use | |
| JPS5941946B2 (en) | porcelain | |
| JPS62295666A (en) | Continuous two-dimensional porous implant material and its production | |
| JPH0359703B2 (en) | ||
| US20020136696A1 (en) | Orthopedic and dental ceramic implants | |
| JPS6179464A (en) | Composition for artificial bone material | |
| JPH0215221B2 (en) | ||
| JPH0575427B2 (en) | ||
| JPH0325181B2 (en) | ||
| JPS6179463A (en) | Composite apatite artificial bone material | |
| JP4866765B2 (en) | Calcium phosphate sintered porous body and calcium phosphate sintered porous granule | |
| JPS6212680A (en) | Block-form apatite sintered body | |
| JP2576404B2 (en) | Bone defect, bone void and bone resorbing part manufacturing method | |
| JPH0588623B2 (en) | ||
| JPH01107769A (en) | Osteoprosthetic agent | |
| JPS62270164A (en) | Substitute material for repairing living body hard tissue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |